Topic Archives: Social Capital Hedosophia II (IPOC)

If my limited interactions with the outside world are any indication, I’d say we’ve gotten to the “cab driver” period that institutional investors often talk about: When your cab driver starts giving you stock tips, the top is probably near. That’s not a reliable predictor, of course, and I guess it would be Uber drivers […]

Comments

  • Avatar

    AS of Aug 15, the newsletter pitch is the same, something happening soon, Dylan says: https://go.behindthemarkets.com/li...

  • Avatar

    Latest News by Jeff Brown, “FDA Fast Tracks $6.8 Billion Miracle Antibiotic for July Approval One microcap owns the ...

  • Travis Johnson, Stock Gumshoe

    I assume you mean Jeff Brown, no? Not Jeff Bezos (of Amazon)? Brown has indeed been touting Editas for a long time...

  • Avatar

    I'll be the first to admit I've taken some long shots over the years, the most recent being CRNT. Hopefully, CRNT will b...

  • Avatar

    Thank you for your thoughtful detailing on the processes currently underway and in realignment in the scale of time invo...

  • SoGiAm

    Unravelling mystery of how, when DNA replicates https://www.sciencedaily.com/releases/2018/12/181227150644.htm Have an a...

  • Avatar

    Thanks MJ, This is the real reason I read stockgumshoe.Having worked in the “Health care” profession for decad...

  • Avatar

    Cancer treatment and info on this company stock symbol. What is crispr company stock symbol? Thank you! Greatly appreci...

  • Avatar

    Drug companies cant touch this tech, without paying DEARLY for licensing. CRISPR tech is getting to the root of the pro...

  • Avatar

    There've been a lot of uncertainties around the CRISPR companies, but I think right now the elephant in the room is the ...

  • Michael Jorrin,

    Many highly interesting comments for which many thanks. I will attempt to respond (& perhaps actually answer) to as ma...

  • Avatar

    You failed to mention advancements covering the efficacy of CRISPR technology...

  • Avatar

    It's got to be one of the three small biotechs that have access to CRISPR - Crispr Therapeutics (CRSP), Intellia Therape...

  • Avatar

    Good plan, Dave. I'm 58, do not have time to GAMBLE with hard-earned cash. DRIP plans invested in solid companies tha...

  • Travis Johnson, Stock Gumshoe

    A good perspective. And when it comes to Sangamo, it seems to me that Zinc Finger "editing" is 10-20 years ahead of CRI...

  • Avatar

    CRISPR might eventually be able to edit the human genome safely, but we are years away from that, assuming scientificall...

  • Avatar

    So the Big Parma influenced FDA is going to cut the throat of the medical mafia, which is almost 20% of our GDP, by sanc...

  • Avatar

    It’s Editas, MIT and Harvard have been in a patent battle with Berkeley and Berkeley lost. It’s my understanding th...

  • Avatar

    Crispr, CRSP, EDIT, NTLA are all promising companies, as is Beam Therapeutics (private company)....

  • Avatar

    I have recently become aware of two books, 'The Telomerase Revolution' by Dr. Michael Fossel and 'A Crack In Creation' b...

  • Avatar

    Well, this one would have been a pretty good buy... having doubled since the promotional piece was written. The other cr...

  • SoGiAm

    $YTEN, $CLXT fp & #CRISPR stocks... Eatin' CRISPR food in 5 years maybe https://www.ozy.com/fast-forward/you-could-b...

  • Travis Johnson, Stock Gumshoe

    Those are certainly the primary CRISPR names that get teased all the time, though I haven't looked at that actual ad yet...

  • SoGiAm

    $JNJ, $GILD, #EDIT etc. - As gene editing explodes, a new report from Goldman says Chinese groups are seizing the lead o...

  • Avatar

    Regarding CRISPR technology, Has anyone investigated the NEXGEN teaser about a $200 biotech stock that could reach 1 mil...

  • Avatar

    Market analysts believe that the patent dispute will conclude in the most common way observed in the past cases – both...

  • Avatar

    I wouldn't put too much credence in the Fool's CRISPR doomsayer act. The paper cited by the Fool suggests ways around th...

  • SoGiAm

    Hi John, Here's a couple of articles on the concern: Arbor Biotechnologies Discovers New CRISPR System Utilizing its ...

  • Avatar

    backoffice, According to The Motley Fool, almost all CRISPR stocks are headed to 0. Not sure that I agree with their...

  • Avatar

    There are a lot of rare/orphan diseases that no big pharma companies will touch that could be impacted by CRISPR technol...

  • Avatar

    Ha!! Caught again - thank you for being the best detective on Market Street....

  • Travis Johnson, Stock Gumshoe

    CRISPR is a research tool/technique, not a drug. The first uses of CRISPR in humans are just beginning with initial cli...

  • Avatar

    Readers may be interested in looking at the January 2018 JP Morgan Healthcare presentation by SGMO. Their gene editing ...

  • Avatar

    I like instead the company Sangamo (SGMO). Their gene editing technology (zinc finger) appears more robust and safer th...

  • Avatar

    The technology, research and development behind the three forerunners on the CRISPR gene editing front is so hyped that ...

  • Travis Johnson, Stock Gumshoe

    Incidentally, this patent fight between the major CRISPR "discovery" researchers and their respective institutions does ...

  • Avatar

    Yes, its Editas (EDIT). But the patent dispute was resolved a year ago. Not new news. They do have a good proprietary...

  • Avatar

    When I checked the worth of each company mentioned above I found that a smaller company may also be involved in the actu...

  • Avatar

    Please see following article: "Court Rules Against Berkeley CRISPR Patent (//www.investopedia.com/news/court-rules-again...

  • Avatar

    $CAPR, the rest of the market and institutions have no faith in CAPR. What could go wrong here. Besides it's one of the ...

  • Avatar

    I looked into SGNO and their method of zinc fingers seems to have had successful tests so far and they eluded that CRISP...

  • SoGiAm

    $CLLS - Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells http://www.cellectis.com/en/press/two-i...

  • Avatar

    $NoTicker...maybe $CRISPR? Cooking this week has been rough. Several bad slices and almost lost a finger tip. I hope ...

  • Avatar

    $GeneEditing $CRISPR Beautiful. Thank you!...

  • Avatar

    $GeneEditing $CRISPR “CRISPR gene-editing systems 3D animation (video)” #Fantastic Video - watch what it actu...

  • SoGiAm

    The Chart of the Day belongs to CRISPR Therapeutics (CRSP). I found the Biomedical stock by using Barchart to sort toda...

  • SoGiAm

    $DFFN in & swingin' - 8K & exhibits filed with the SEC http://www.snl.com/Cache/c391818209.html view all docz http://in...

  • SoGiAm

    Goldman: Setting the stage for oncology M&A in 2018 Tax reform unlocks ~$160bn ex-US cash for potential M&A Potential ...

  • SoGiAm

    #CRISPR - Crispr Therapeutics AG (NASDAQ: $CRSP) was the recipient of unusually large options trading on Thursday. In...

  • Avatar

    CrIspr Disappointing. Dreams dashed of becoming hollywood tv gameshow host if I'm immune, and they can't switch off a...

  • Avatar

    #ARTH out but decided to begin getting back in with some lifting of the haze; #conference call: Just a quick monster t...

  • Avatar

    Uh Oh—CRISPR Might Not Work in People A sampling of human blood has turned up a surprise: most people could be ...

  • Avatar

    Doc/Cleveland/Helen others- as a relatively new member of the community I can't tell you how much your deep insight has ...

  • Avatar

    #GeneTherapy #CRISPR #DMD Interesting article from the MIT Technology Review about CRISPR and Gene Therapy both in gene...

  • SoGiAm

    This Startup Has a New CRISPR Enzyme - And Says It Will Give It Away For Free https://www.forbes.com/sites/matthewherper...

  • DrKSSMDPhD

    Changes to NBI and thus to IBB. The changes reflect equity relevance in the market: Added: Arbutus (NASDAQ:ABUS), Acl...

  • Avatar

    Read an article on Yahoo Finance recently from the Motley Fool talking about Disruptor Stocks. While no mention of CRIS...

  • Avatar

    God Key = CRISPR Comapnies holding ip's - Intellia, CRISPR Therapeutics and Editas...

  • Avatar

    To the best of my knowledge, Editas, Dr Church's company (EDIT) has the sole CRISPR license from the Broad Foundation, a...

  • Avatar

    Sangamo (SGMO)uses zinc fingers which appears to have an advantage over CRISPR. More precise....

  • Travis Johnson, Stock Gumshoe

    Eiger BioPharmaceuticals isn't a gene therapy company, from what I can tell, though there are certainly plenty of gene t...

  • Avatar

    CRISPR is cool and all, but until the massive issues with off-target effects are sorted out I can't see it making a huge...

  • Avatar

    Typo: should read CRISPR, sorry!....

  • Avatar

    Hi deano1, It's not a six million dollar company. It had 6 million in revenues and the company is EDIT . This is an o...

  • Avatar

    I just read a Harvard U article on CRISPR which leads to me to believe this thing is moving forward. I own a small, 1.7%...

  • Avatar

    Here is a basic layman's article on CRISPR. It appears to be well sourced. New CRISPR Tools enable extraordinarily p...

  • Avatar

    $CRISPR Weekend reading: Researchers use gold nanoparticles to deliver CRISPR-Cas9 and correct a point mutation in a m...

  • Avatar

    Hi SoGiAM, I have searched up and down the site and don't find a gummy position on CRISPR., gene therapy. EDIT, CRSP, NT...

  • SoGiAm

    #crisprgold hashtag on Twitter #XDMD #DMD $SRPT $CAPR zowz news.berkeley.edu/.. Gold nanoparticle used to replace vir...

  • Avatar

    With relevance to: $SRPT $CAPR $CATB $DMD CRISPR-Gold' Fixes Duchenne Muscular Dystrophy Mutation in Mice (10/4) B...

  • Avatar

    $Gene Editing $Glaucoma University Of Iowa Researchers Use CRISPR Engineering To Prevent Certain Glaucoma In Mice ...

  • Avatar

    ZGNX thoughts from Paul Matheis (no opinion from me): Overall belief that risk-reward is good. Quite hopeful the trial...

  • Avatar

    For those interested in the science behind the discovery and early development of CRISPR-CAS9 gene editing technology, I...

  • Michael Jorrin,

    Some form of CRISPR technology will successfully target A disease - not hundreds or thousands. And some CRISPR outfit ...

  • Avatar

    I can't share any experience with that particular newsletter (I despise $1500/year newsletters in general), but I can sh...

  • Avatar

    Cellectis Wins CRISPR Patent in Europe Jonathan Wosen, GEN News Highlights, 25 July 2017, http://www.genengnews.com/g...

  • Avatar

    Headlines & News go t GlobeNewswire 8/22/2017 7:30:00 AM CRISPR Therapeutics Announces Collaboration with Massachu...

  • SoGiAm

    Malicious code written into DNA infects the computer that reads it https://techcrunch.com/2017/08/09/malicious-code-wri...

  • SoGiAm

    $EDIT np related - RNA-targeting CRISPR could yield treatments for Huntington's, ALS http://www.fiercebiotech.com/resea...

  • SoGiAm

    $SGMO xenotransplantation zinc finger gene editing pigs for transplanting organs into human #lung #pancreas #heart #li...

  • arch1

    kristilee1 Possible? Probably. You can bet that Fort Dietrich has been working on weaponizing bacteria,,, and virus, ...

  • Avatar

    there are several companies doing ''gene editing''. CRISPR is one....

  • SoGiAm

    $MRTX np, $EPZM np - #Chromatin So much attention for #CRISPR on DNA, but it's also elucidating epigenetics The epig...

  • SoGiAm

    $MRK np - CRISPR patent battle in Europe takes a ‘wild’ twist with surprising player http://www.sciencemag.org/news...

  • SoGiAm

    #CRISPR #Bioethics -$EDIT np $NTLA np $CLLS long etc... - http://www.spokesman.com/stories/2017/aug/05/the-ethics-of-cr...

  • Avatar

    I just read that the Dept of Defense is getting involved with CRISPR and the c-9 (sp?) DNA editing process to make sure...

  • Avatar

    my gut tells me it could be a one of these but Travis or others could help pin point. Editas, (edit) Cymabay (cbay) Inte...

  • Avatar

    so my gut tells me it could be a one of these but Travis or others could help pin point. Editas, (edit) Cymabay (cbay) I...

  • maddogdne

    This company was heavily teased 2 years ago, when they apparently thought that the patent fight in court would be over q...

  • SoGiAm

    #CRISPR - First Human Embryos Edited in U.S. https://www.technologyreview.com/s/608350/first-human-embryos-edited-in-...

  • Avatar

    Two interesting links from the latest Labiotech.eu newsletter: “Cutting Through the BS in Biopharma: How To Spot Hy...

  • DrKSSMDPhD

    Some annotations: Mixed emotions on $GNFTF. No position. THIS SPACE IS EVOLVING RAPIDLY and while GenFit's elafibrinor w...

  • Avatar

    $noticker Boom in human gene editing as 20 CRISPR trials gear up A pioneering CRISPR trial in China will be the first ...

  • Avatar

    $ EDIT fp Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR...

  • SoGiAm

    #Zika - Mosquitoes swat back via resistance to CRISPR gene drive http://www.ipscell.com/2017/02/mosquitoes-swat-back-vi...

  • SoGiAm

    Mosquitoes swat back via resistance to CRISPR gene drive http://www.ipscell.com/2017/02/mosquitoes-swat-back-via-resist...

  • JohnM

    Prior post awaiting moderation, but this is timely Starting now Slingshot Insights Expert Interview @ 1PM EST - Join...

  • JohnM

    Starting in a few minutes Slingshot Insights Expert Interview @ 1PM EST - Join us for an in-depth conversation on CRI...

  • SoGiAm

    $EDIT $NTLA $CRSP...np any of 3 CRISPR heavyweights battle in US patent court http://www.nature.com/news/crispr-heavy...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info